Pharmacophore Modeling, Docking and Molecular Dynamics Studies on Caspase-3 Activators Binding at β-Tubulin Site

E-ISSN： 1875-6697|11|1|72-83

ISSN： 1573-4099

Source： Current Computer - Aided Drug Design, Vol.11, Iss.1, 2015-01, pp. : 72-83

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Molecular Docking and Pharmacophore Modeling Studies of Fluorinated Benzamides as Potential CETP Inhibitors

Medicinal Chemistry, Vol. 13, Iss. 3, 2017-04 ,pp. : 239-253

Bentham Science Publishers

Access to resources Recommend Favorite

Identification of Novel IRAK-4 Inhibitors Through Pharmacophore Modeling, Atom-based 3D-QSAR, Docking Strategies and Molecular Dynamics Simulation

Letters in Drug Design & Discovery, Vol. 13, Iss. 9, 2016-11 ,pp. : 879-887

Bentham Science Publishers

Access to resources Recommend Favorite

Identification of Potent Caspase-3 Inhibitors for Treatment of Multi- Neurodegenerative Diseases Using Pharmacophore Modeling and Docking Approaches

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 13, Iss. 8, 2014-10 ,pp. : 1346-1353

Bentham Science Publishers

Access to resources Recommend Favorite

In silico Studies Toward the Discovery of Novel Type-II Inhibitors of TrkA: Pharmacophore-based 3D-QSAR Modeling, Database Screening and Molecular Docking

Letters in Drug Design & Discovery, Vol. 13, Iss. 6, 2016-06 ,pp. : 526-538

Bentham Science Publishers

Access to resources Recommend Favorite

Mutants yield a pharmacophore model for the tubulin-paclitaxel binding site

By Day B.W.

Trends in Pharmacological Sciences, Vol. 21, Iss. 9, 2000-09 ,pp. : 321-323

Elsevier

Access to resources Recommend Favorite